Please assess the completion status of the following clinical trial:

Trial Title: Effect of High Dose Fish Oil Supplementation After Recent Heart Attack Using Magnetic Resonance Imaging

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Experienced a heart attack in the 2 to 4 weeks before study entry~* Lives in the greater Boston area or adjacent regions (within a 50-mile radius of Boston)~Exclusion Criteria:~* Unable to undergo an MRI because of metallic implants (e.g., pacemakers, an implantable cardioverter defibrillator \[AICD\]) at time of study entry~* Active cancer or any other terminal illness with an expected survival rate of less than 6 months after study entry~* Significant kidney dysfunction with a glomerular filtration rate (GFR) of less than 60 mL/min in the 2 weeks before study entry~* Inability to follow study procedures~* Pregnant~* Hemodynamic instability~* Urgent clinical need for a pacemaker or AICD~* Inaccessibility of medical records

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Omega-3 Fatty Acids (Type: EXPERIMENTAL): Participants will receive a highly purified form of omega-3 fatty acids for 6 months.
- Placebo (Type: PLACEBO_COMPARATOR): Participants will receive placebo for 6 months.

Based on this trial design, predict the completion outcome and termination type (if applicable).